Dr. Jonathan S. Treisman, MD | Franklin ...

Dr. Jonathan S. Treisman

Claim this profile

Ascension Saint Elizabeth Hospital

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
15 reported clinical trials
32 drugs studied

Area of expertise

1Lung Cancer
Jonathan S. Treisman has run 4 trials for Lung Cancer. Some of their research focus areas include:
Stage III
Stage II
Stage IV
2Non-Small Cell Lung Cancer
Jonathan S. Treisman has run 4 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II

Affiliated Hospitals

Image of trial facility.
Ascension Saint Elizabeth Hospital
Image of trial facility.
Ascension Mercy Hospital

Clinical Trials Jonathan S. Treisman is currently running

Image of trial facility.

Financial Navigation

for Cancer Patients

This clinical trial evaluates the effect of Cost Communication and Financial Navigation (CostCOM) intervention on adherence to care and financial burden in cancer patients. Many cancer patients experience financial hardship due to high medical out of pocket costs (OOPC), changes in employment, income and insurance. Financial hardship can lead to a delay or a stop in cancer care, and is linked to poor quality of life. Financial navigation programs, such as CostCOM, provide financial counseling, education and connections to appropriate resources to reduce financial barriers to healthcare and minimize financial stress and burden. CostCOM may improve adherence to care and decrease financial burden in patients with cancer.
Recruiting1 award N/A
Image of trial facility.

Mobile Health

for Breast Cancer

This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.
Recruiting1 award N/A10 criteria

More about Jonathan S. Treisman

Clinical Trial Related6 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 7 Active Clinical Trials
Treatments Jonathan S. Treisman has experience with
  • Biospecimen Collection
  • Paclitaxel
  • Carboplatin
  • Pembrolizumab
  • Lenalidomide
  • Crizotinib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Jonathan S. Treisman specialize in?
Is Jonathan S. Treisman currently recruiting for clinical trials?
Are there any treatments that Jonathan S. Treisman has studied deeply?
What is the best way to schedule an appointment with Jonathan S. Treisman?
What is the office address of Jonathan S. Treisman?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security